Grazier_Matthew_1_web

Matt Grazier



Matt Grazier is a corporate partner in Nixon Peabody’s Private Equity & Investment Funds practice group in Los Angeles, California.

What do you focus on?

I have extensive experience handling a full range of corporate transactions, including acquisitions, dispositions, mergers, leveraged buy-outs, tender offers, reorganizations, and joint ventures. In addition, I counsel clients with venture capital and growth equity financings, and corporate governance and compliance matters.

My focus is primarily on the following industries: information technology, software, consumer-facing health technology, life sciences, medical devices, consumer products, food and beverage, media, energy and aerospace.

I am fortunate to handle significant matters for my clients, and my approach is to efficiently manage all aspects of the deal process while simultaneously allowing my clients the ability to successfully oversee their companies and funds. Serving as a trusted advisor and helping my clients reach successful results is my top priority.

Mergers and Acquisitions

I assist companies and private equity funds in structuring and negotiating a variety of M&A transactions, including stock and asset acquisitions, mergers, tender offers and leveraged buy-outs.

Growth Equity Investments and Capital Raises

I regularly represent private equity, venture capital and strategic investors as well as health systems in connection with their growth equity investments.  In addition, I often sit on the other side of the table and team with my corporate clients to strategically raise capital through a variety of equity and debt financings, including venture capital financings and PIPE transactions.

Outside General Counsel

I act as outside general counsel to many companies and assist those companies with respect to financing strategies, commercial contracts and corporate governance and senior management issues.

What do you see on the horizon?

High-quality assets should continue to demand higher valuations and competition for those assets will remain fierce. However, I expect that overall valuations in the middle market will flatten a bit with concerns over global economic instability and the anticipated gradual increase of interest rates.

Presentations

  • Speaker, “Corporate & Financing Basics,” LA BioStart Legal Basics Program, August 2018
  • Speaker, “Corporate & Financing Basics,” LA BioStart Legal Basics Program, February 2018
  • Speaker, “Preparing Life Sciences Companies for Chinese Opportunities,” Office of Economic Development, July 2017
  • Speaker, “Corporate & Financing Basics,” LA BioStart Legal Basics Program, July 2017
  • Speaker, “Legal Issues for Digital Health Companies,” Cedars-Sinai Medical Center Healthcare Accelerator, February 2017
  • Moderator, “2017 Private Equity and M&A Outlook – Trends & Opportunities,” Nixon Peabody Hot Topics in the Middle Market, February 2017
  • Presenter, “Legal Considerations in Starting Your Company,” Technology Transfer Office, Cedars-Sinai, February 2017
  • Moderator, “Private Equity Investing Outlook: What is Next for Fundraising,” Nixon Peabody Hot Topics in the Middle Market, May 2016
  • Presenter, "Investing in Technology Companies," 11th Annual California MCLE Super Seminar-Los Angeles, January 2016
  • Moderator, “Private Equity and M&A Outlook: Trends & Opportunities,” Nixon Peabody Hot Topics in the Middle Market, January 2016
  • Presenter, “Providers as Innovators, Investors and Customers in Digital & Consumer-Facing Health Care,” October 2015
  • Moderator, “Private Equity Investing Outlook: What is Next for Fundraising,” Nixon Peabody Hot Topics in the Middle Market, September 2015
  • Moderator, “Private Equity Investing Outlook: What is Next for Consumer Products & Services,” Nixo Peabody Hot Topics in the Middle Market, April 2015
  • Moderator, “Private Equity and M&A Outlook: Trends & Opportunities,” Nixon Peabody Hot Topics in the Middle Market, December 2014
  • Moderator, “Investing in Disruptive Health Care Technologies,” Nixon Peabody Hot Topics in the Middle Market, May 2014
  • Moderator, “Investing in Health Care: Opportunities & Challenges Ahead,” Nixon Peabody Hot Topics in the Middle Market, June 2013
  • Presenter, “Show Me the Money: Private Placement Reform and Crowdfunding,” Eighth Annual California MCLE Symposium - San Francisco, January 2013
  • Presenter “IPO Bootcamp - Southern California,”  presented by Nixon Peabody, KPMG and the New York Stock Exchange, April 2012

The dealmaker behind the San Francisco Museum of Modern Art and Fisher Family partnership

Art Daily | May 16, 2016

This article features Nixon Peabody’s role as deal counsel and advisor to San Francisco Museum of Modern Art (SFMOMA) and the Fisher Family to create a first-of-its-kind collaboration between a museum and a collection. Los Angeles partner and Arts & Cultural Institutions leader Thad Stauber led the NP team in this unprecedented agreement with support from Washington, DC, partner Mike Cooney and Los Angeles partner Matt Grazier. SFMOMA opened to the public on May 14, featuring an expansive new addition displaying hundreds of pieces of postwar and contemporary art work from the Fisher Family.

Contact

Matt Grazier

Partner

Los Angeles

Phone: 213-629-6096


Fax: 866-216-9523

Georgetown University Law Center, J.D., (Notes and Articles Editor, Journal of Law and Policy in International Business)

Colorado State University, B.S., Business Administration, cum laude

California

Back to top